Study of a new drug for advanced solid tumors
Part of Cancer clinical trials.
This trial tests a new drug, SCTB39G, for people with advanced solid tumors that haven't responded to other treatments. The goal is to see if it can shrink tumors and improve survival, and to find the best dose. Participation involves regular treatment and check-ups.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 70 years old.
- You have been diagnosed with an advanced solid tumor (a type of cancer that has spread).
- You have at least one tumor that can be measured on a scan.
- You are generally well enough to perform daily tasks (ECOG score 0 or 1).
- You have adequate organ and bone marrow function.
- You are not pregnant or breastfeeding and are not planning to become pregnant during the trial.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new drug called SCTB39-1 for people with advanced solid tumors that have not responded to other treatments. The study has two parts: first finding the right dose, then testing how well it works.
This trial tests two new study drugs (SCTB41 and SCTB39-1) given together, sometimes with standard treatment, to see if they are safe and effective against advanced solid tumors. If you join, you will receive these drugs and be monitored for how well they fight the cancer.
This trial tests a combination of two experimental drugs, MHB088C and MHB039A, for people with advanced solid tumors that have not responded to standard treatments. The goal is to see if this combination can shrink tumors and help patients live longer.
This trial tests a new drug (SI-B036) for people with advanced urological tumors or other solid tumors that have spread. The goal is to see if the drug is safe and effective, and it might help shrink tumors or slow their growth.
This trial tests a new combination of two investigational drugs (SCTB41 and SCTB39G), sometimes given with standard treatment, for advanced solid tumors. The goal is to see if this approach can shrink tumors and control the cancer, and it may be an option for people who have exhausted standard treatments.
This trial tests a new drug called SCTB41 in people with advanced solid tumors that have not responded to other treatments. The goal is to see if it is safe and if it shrinks tumors.
Hear when a new Advanced Malignant Solid Neoplasm trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.